✦ LIBER ✦

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA

✍ Scribed by Martinot-Peignoux, Michelle; Lapalus, Martine; Laouénan, Cédric; Lada, Olivier; Netto-Cardoso, Ana Carolina Ferreira; Boyer, Nathalie; Ripault, Marie Pierre; Carvalho-Filho, Roberto; Asselah, Tarik; Marcellin, Patrick

Book ID: 121016447
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 695 KB
Volume: 58
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2013.08.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

10 HBV-DNA markers predictive of respons

10 HBV-DNA markers predictive of response to lamivudine (LAM) therapy in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B

✍ A. Ciancio; A. Smedile; M. Rizzetto; M. Lagget; A. Olivero; M.L. Abate; J. Gerin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

P697 SERUM LEVELS OF HEPATITIS B SURFACE

P697 SERUM LEVELS OF HEPATITIS B SURFACE ANTIGEN (HBsAg) PREDICT HEPATIC FIBROSIS SEVERITY IN E ANTIGEN-POSITIVE CHRONIC HEPATITIS B (HBeAg+VE CHB) PATIENTS

✍ Marcellin, P.; Martinot-Peignoux, M.; Lau, G.; Liaw, Y.-F.; Messinger, D.; Rothe 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Prediction of significant fibrosis and c

Prediction of significant fibrosis and cirrhosis in hepatitis B e-antigen negative patients with chronic hepatitis B using routine parameters

✍ Yan Wang; Ming-Yi Xu; Rui-Dan Zheng; Jian-Chun Xian; Hong-Tao Xu; Jun-Ping Shi; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

Efficacy of lamivudine in patients with

Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Hepatitis B core antigen in hepatocytes

Hepatitis B core antigen in hepatocytes from liver biopsies of patients with chronic hepatitis B virus (HBV) infection: Correlation with serum HBV-DNA and liver histology

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 73 KB

OL-027 The correlation of serum HBV DNA,

OL-027 The correlation of serum HBV DNA, HBeAg and HBsAg contents in HBsAg-positive chronic hepatitis B patients treated with interferon

✍ Yao Xie; Ming-hui Li; Li-jun Chen; Guo-hua Qiu; Yao Lu; Dao-zhen Xu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB